Surmodics Inc
NASDAQ:SRDX

Watchlist Manager
Surmodics Inc Logo
Surmodics Inc
NASDAQ:SRDX
Watchlist
Price: 28.81 USD 0.38%
Market Cap: 411.7m USD

Wall Street
Price Targets

SRDX Price Targets Summary
Surmodics Inc

Wall Street analysts forecast SRDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SRDX is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.

Lowest
Price Target
43.43 USD
51% Upside
Average
Price Target
43.86 USD
52% Upside
Highest
Price Target
45.15 USD
57% Upside
Surmodics Inc Competitors:
Price Targets
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
5% Upside
300633
SonoScape Medical Corp
30% Upside
ELN
El En SpA
10% Upside
ZBH
Zimmer Biomet Holdings Inc
21% Upside
MEDI
Medistim ASA
14% Downside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
38% Upside
PDEX
Pro-Dex Inc
25% Upside
9996
Peijia Medical Ltd
11% Upside

Revenue
Forecast

Revenue Estimate
Surmodics Inc

For the last 8 years the compound annual growth rate for Surmodics Inc's revenue is 7%. The projected CAGR for the next 3 years is 1%.

7%
Past Growth
1%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Surmodics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
21%
Average Beat

Net Income
Forecast

Net Income Estimate
Surmodics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SRDX's stock price target?
Price Target
43.86 USD

According to Wall Street analysts, the average 1-year price target for SRDX is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.

What is Surmodics Inc's Revenue forecast?
Projected CAGR
1%

For the last 8 years the compound annual growth rate for Surmodics Inc's revenue is 7%. The projected CAGR for the next 3 years is 1%.

Back to Top